199 related articles for article (PubMed ID: 24730732)
1. Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels.
Avihingsanon A; Jitmitraparp S; Tangkijvanich P; Ramautarsing RA; Apornpong T; Jirajariyavej S; Putcharoen O; Treeprasertsuk S; Akkarathamrongsin S; Poovorawan Y; Matthews GV; Lange JM; Ruxrungtham K;
J Gastroenterol Hepatol; 2014 Sep; 29(9):1706-14. PubMed ID: 24730732
[TBL] [Abstract][Full Text] [Related]
2. Prediction of liver stiffness by serum indexes in HCV-infected patients with or without HIV coinfection.
Merchante N; Mena Á; Pascasio JM; Marco A; Rodriguez M; Hernandez-Guerra M; Simón MA
Medicine (Baltimore); 2021 Nov; 100(46):e27838. PubMed ID: 34797315
[TBL] [Abstract][Full Text] [Related]
3. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
[TBL] [Abstract][Full Text] [Related]
4. Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients.
Mazzola G; Adamoli L; Calvaruso V; Macaluso FS; Colletti P; Mazzola S; Cervo A; Trizzino M; Di Lorenzo F; Iaria C; Prestileo T; Orlando A; Di Marco V; Cascio A
Infection; 2019 Jun; 47(3):409-415. PubMed ID: 30519966
[TBL] [Abstract][Full Text] [Related]
5. Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers.
Vermehren J; Vermehren A; Mueller A; Carlebach A; Lutz T; Gute P; Knecht G; Sarrazin C; Friedrich-Rust M; Forestier N; Poynard T; Zeuzem S; Herrmann E; Hofmann WP
BMC Gastroenterol; 2012 Mar; 12():27. PubMed ID: 22453133
[TBL] [Abstract][Full Text] [Related]
6. Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.
Vidovic N; Lochowsky RS; Goldmann G; Rockstroh J; Wasmuth JC; Spengler U; Sauerbruch T; Lammert F; Oldenburg J; Grünhage F
Haemophilia; 2010 Sep; 16(5):778-85. PubMed ID: 20331759
[TBL] [Abstract][Full Text] [Related]
7. HCV co-infection and markers of liver injury and fibrosis among HIV-positive childbearing women in Ukraine: results from a cohort study.
Bailey H; Nizova N; Martsynovska V; Volokha A; Malyuta R; Cortina-Borja M; Thorne C;
BMC Infect Dis; 2016 Dec; 16(1):755. PubMed ID: 27955711
[TBL] [Abstract][Full Text] [Related]
8. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
[TBL] [Abstract][Full Text] [Related]
9. Decline in serum 25 hydroxyvitamin D levels in HIV-HBV-coinfected patients after long-term antiretroviral therapy.
Avihingsanon A; Apornpong T; Ramautarsing RA; Ubolyam S; Tangkijvanich P; Ananworanich J; Lange JM; Matthews G; Lewin SR; Ruxrungtham K;
Antivir Ther; 2014; 19(1):41-9. PubMed ID: 23970149
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of liver enzymes and inflammatory biomarkers for the severity of liver fibrosis stage in HIV/HCV co-infected patients.
Charpentier C; Champenois K; Gervais A; Landman R; Joly V; Le Gac S; Larrouy L; Damond F; Brun-Vézinet F; Descamps D; Yazdanpanah Y
PLoS One; 2013; 8(3):e59205. PubMed ID: 23527135
[TBL] [Abstract][Full Text] [Related]
11. Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.
Castera L; Winnock M; Pambrun E; Paradis V; Perez P; Loko MA; Asselineau J; Dabis F; Degos F; Salmon D
HIV Med; 2014 Jan; 15(1):30-9. PubMed ID: 24007567
[TBL] [Abstract][Full Text] [Related]
12. The Association of PNPLA3, COX-2 and DHCR7 Polymorphisms with Advanced Liver Fibrosis in Patients with HCV Mono- Infection and HCV/HIV Co-Infection.
Kiatbumrung R; Chuaypen N; Payungporn S; Avihingsanon A; Tangkijvanich P
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2191-2197. PubMed ID: 30139224
[TBL] [Abstract][Full Text] [Related]
13. Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.
Mandorfer M; Payer BA; Schwabl P; Steiner S; Ferlitsch A; Aichelburg MC; Stättermayer AF; Ferenci P; Obermayer-Pietsch B; Grabmeier-Pfistershammer K; Trauner M; Peck-Radosavljevic M; Reiberger T
Liver Int; 2015 Mar; 35(3):876-85. PubMed ID: 24905495
[TBL] [Abstract][Full Text] [Related]
14. Transient elastography: a non-invasive tool for assessing liver fibrosis in HIV/HCV patients.
Li Vecchi V; Soresi M; Colomba C; Mazzola G; Colletti P; Mineo M; Di Carlo P; La Spada E; Vizzini G; Montalto G
World J Gastroenterol; 2010 Nov; 16(41):5225-32. PubMed ID: 21049556
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV/HCV-coinfected patients.
Merli M; Galli L; Castagna A; Salpietro S; Gianotti N; Messina E; Poli A; Morsica G; Bagaglio S; Cernuschi M; Bigoloni A; Uberti-Foppa C; Lazzarin A; Hasson H
New Microbiol; 2016 Apr; 39(2):110-3. PubMed ID: 27196548
[TBL] [Abstract][Full Text] [Related]
16. Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection.
Kirk GD; Astemborski J; Mehta SH; Spoler C; Fisher C; Allen D; Higgins Y; Moore RD; Afdhal N; Torbenson M; Sulkowski M; Thomas DL
Clin Infect Dis; 2009 Apr; 48(7):963-72. PubMed ID: 19236273
[TBL] [Abstract][Full Text] [Related]
17. Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort.
Chalouni M; Sogni P; Miailhes P; Lacombe K; Poizot-Martin I; Chas J; Vittecoq D; Neau D; Aumaitre H; Alric L; Piroth L; Bouchaud O; Katlama C; Morlat P; Lascoux-Combe C; Gervais A; Naqvi A; Rosenthal E; Garipuy D; Barange K; Esterle L; Salmon D; Wittkop L;
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1387-1396. PubMed ID: 31033848
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive assessment of liver steatosis and fibrosis in HIV/HCV- and HCV- infected patients.
Li Vecchi V; Giannitrapani L; Di Carlo P; Mazzola G; Colletti P; La Spada E; Vizzini G; Montalto G; Soresi M
Ann Hepatol; 2013; 12(5):740-8. PubMed ID: 24018492
[TBL] [Abstract][Full Text] [Related]
19. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.
Barreiro P; Pineda JA; Rallón N; Naggie S; Martín-Carbonero L; Neukam K; Rivero A; Benito JM; Caruz A; Vispo E; Camacho A; Medrano J; McHutchison J; Soriano V
J Infect Dis; 2011 Jun; 203(11):1629-36. PubMed ID: 21592993
[TBL] [Abstract][Full Text] [Related]
20. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.
Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M
HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
